Collplant Biotechnologies LTCLGN
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 20 institutions reported holding Collplant Biotechnologies LT (CLGN) in their 13F filings, up 4 from Q4 2025. 5 opened new positions and 1 sold out. The largest holders were Villere St Denis J & Co. LLC ($326K), Pinnacle Associates Ltd. ($295K) and Brown Advisory Inc. ($64K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Collplant Biotechnologies LT
- CUSIP
- M2R51X116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $58K |
| Exits | 1 | $4K |
All 13F filers, Q4 2025 → Q1 2026: 168,710 shares bought and 15,464 shares sold, net +153,246 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Villere St Denis J & Co. LLC | 0.04% | No change | 607,300 | $326K |
| Pinnacle Associates Ltd. | 0.00% | Reduce -1.3% | 550,229 | $295K |
| Brown Advisory Inc. | 0.00% | No change | 118,731 | $64K |
| Armistice Capital, LLC | 0.00% | New | 64,000 | $34K |
| Pathstone Holdings, LLC | 0.00% | Add +235.3% | 57,000 | $31K |
| Citadel Advisors | 0.00% | New | 32,165 | $17K |
| Legacy Wealth Managment, LLC | 0.01% | Add +567.6% | 23,179 | $12K |
| Renaissance Technologies | 0.00% | Reduce -4.5% | 16,800 | $9K |
| XTX Topco Ltd | 0.00% | Add +2.9% | 14,795 | $8K |
| Waters Parkerson & Co., LLC | 0.00% | No change | 13,250 | $7K |
| Virtu Financial LLC | 0.00% | Add +6.7% | 12,600 | $7K |
| Two Sigma Securities, LLC | 0.00% | New | 11,357 | $6K |
| FNY Investment Advisers, LLC | 0.00% | Add +0.9% | 5,300 | $2K |
| Group One Trading LLC | 0.00% | Reduce -71.4% | 1,400 | $749 |
| Osaic Holdings, Inc. | 0.00% | Add +3.0% | 345 | $184 |
| Wells Fargo & Company | 0.00% | Reduce -85.0% | 300 | $161 |
| SBI Securities Co., Ltd. | 0.00% | No change | 200 | $107 |
| Simplex Trading, LLC | 0.00% | New | 118 | $63 |
| UBS Group AG | 0.00% | New | 95 | $51 |
| Morgan Stanley | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is CLGN's weight in each manager's 13F, not the share of Collplant Biotechnologies LT the manager owns.